Antoine Yver, MD, MSc, has been appointed global head, Oncology Research and Development, Daiichi Sankyo, Inc. In this newly created role, Dr. Yver will have responsibility for leading all global R&D across the oncology therapeutic area including external investments, internal pipeline decisions, and resourcing requirements. He reports to Glenn Gormley, MD, Ph.D., senior executive officer and global head, R&D, Daiichi Sankyo Co., Ltd. and chairman of the board and president, Daiichi Sank...